Company / Current Liabilities
TREACE MEDICAL CONCEPTS, INC. Current Liabilities History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$30.6M
FY2025
5-year range
$18.2M / $45.0M
FY2021-FY2025
Trend
-12.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $45M to $31M over the past 2 years.
Based on SEC 10-K filings.
$31M in FY2025 with a 3-year CAGR of +0.4%.
Improved from $45M to $31M over the past 2 years.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +0.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +0.4%, indicating consistent growth.
- In FY2025, current liabilities decreased 12.3% year-over-year.
- Peak current liabilities was recorded in FY2023.
- Lowest current liabilities in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 1.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $30.6M | -12.3% |
| FY2024 | $34.9M | -22.4% |
| FY2023 | $45.0M | +48.9% |
| FY2022 | $30.2M | +66.1% |
| FY2021 | $18.2M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026